TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Ascentage Pharma to Present Data from Multiple Studies of Olverembatinib, Including the First Dataset from POLARIS-1 Study, at ASH 2025

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Ascentage Pharma Group International Inc.
Ascentage Pharma to Present Data from Multiple Studies of Olverembatinib, Including the First Dataset from POLARIS-1 Study, at ASH 2025

Ascentage Pharma will present clinical data on olverembatinib at the 67th ASH Annual Meeting, showcasing results from multiple studies in leukemia treatments, including the first dataset from the global Phase III POLARIS-1 study.

Insights
NMHI   positive

Gaining access to advanced blockchain infrastructure for carbon credit verification, expanding environmental impact, and establishing technological leadership in Asian markets


AAPG   positive

Company is presenting multiple clinical studies at a prestigious conference, demonstrating continued research progress and potential treatment advancements in hematological diseases